Mollyycolllinss's Categories
Mollyycolllinss's Authors
Latest Saves
A loooong thread with maps (and no memesâčïž).
So can we do sub-classification?
Many people say ânoâ, like AndrĂ© Bassetâs famous quote: âcette langue sâĂ©parpille directement ou Ă peu prĂšs en une poussiĂšre de parlers de 4 Ă 5 mille peut ĂȘtreâ (1952:1) and Alfred Willms (1980). Others are a bit more nuanced.
For example, the fantastic studies by Lafkioui (https://t.co/hHKMgEPjK2) give a synchronic classification of Tarifiyt dialects. To cut a very long story irresponsibly short: all variables are counted the same.
However, we should ask ourselves: Does this continuum hide a more discontinuous past? Has there never been major disruption, or has much of it been smoothed out by later convergence?
In order to study this, one has to classify variables and their isoglosses. Some variables are continuous and can be assigned to the latest convergence period. Others are clustered in a group unrelated to the continuum. Still others are scattered.
Letâs take a look at a couple of them and shiver at their
Amazigh (Berber) languages are quite close to each other and in most places nearby varieties are mutually intelligible. They function like a discontinuous dialect continuum.
— Maarten Kossmann (@ait_kisou) January 12, 2021
A loooong thread with maps (and no memes\u2639\ufe0f).
(1) The 2SG subject marker on the verb.
GREEN: -d
YELLOW -t (possibly a development from -d)
ReRED: -áž / -áč
There is no regular phonetic correspondence of -d to -áž.

(2) In most varieties *ÎČ became (or remained?) /b/ in pre-consonantal position (GREEN). In a number of varieties, this didnât happen (RED).

(3) The Imperative M:PL suffix is -at in western Morocco AND in Awjila (Libya) (RED). It is -Ét / -Ät elsewhere (GREEN). The yellow part has different suffixes.

(4) The pharyngealized (âemphaticâ) non-geminated alveolar is [dË] (or [ðË]) in most of Amazigh (GREEN), but in a scattered number of varieties, it is [tË] (RED).

In the last three months, tech giants have censored political speech and journalism to manipulate U.S. politics -- banning reporting on the Bidens, removing the President, destroying a new competitor -- while US liberals, with virtual unanimity, have cheered.
The ACLU said the unity of Silicon Valley monopoly power to destroy Parler was deeply troubling. Leaders from Germany, France and Mexico protested. Only US liberals support it, because the dominant strain of US liberalism is not economic socialism but political authoritarianism.
https://t.co/qD9OdwlPbV

Just three months ago, a Dem-led House Committee issued a major report warning of the dangers of the anti-trust power of Apple, Amazon, Google and Facebook. Left-wing scholars have been sounding the alarm for years. Now it's here, and liberals
We wrote a 200 page report on why corporate concentration - including the big tech radicalization engines - worsened under both Democratic and Republican administrations. It has to do with antitrust enforcement, and it's fixable by Biden. https://t.co/K85Kv34t83
— Matt Stoller (@matthewstoller) January 12, 2021
A thread in which I prove (using ONLY published Pfizer trial data) that the UK CMOs and JCVI have not so much ignored the science, as left it bleeding at the roadside.
Intrigued?
Read
The trial data said that after a single dose of the Pfizer vaccine coverage was 52%. Six days after the second dose that rose to nearly 91%. The new policy to delay 2nd dose is based on the idea that the 91% was in fact due to the first dose. We must hope that is true.
— Krishnan Guru-Murthy (@krishgm) December 30, 2020
From the moment, the decision was announced to delay 2nd vaccine doses, I've felt uneasy.
This is not my field of expertise, but I trained as a scientist (two chemistry degrees), worked professionally in IT, and understand the importance of testing.
My principal concern was about the Pfizer vaccine.
As vaccines go, it's "new tech", the first mRNA vaccine and the results are stunning.
Perhaps one should be cautious about deviating from a clinical trial procedure, at least until there is greater experience of mRNA vaccines?
I've been investigating this for over a week and haven't been able to sleep properly since I started.
At best, the 12 weeks strategy was based on one critical assumption, namely that the 2nd dose has NO effect on efficacy in the first 7 days after it is given.
And if it did?
My journey started with a friend pointing me towards an article in @bmj_latest which indicated that a single dose of @pfizer vaccine had an efficacy of